Pilot study of topical medicine of rapamycin for large diffuse plexiform neurofibroma of neurofibromatosis type 1 Pilot study of topical medicine of rapamycinfor large diffuse plexiform neurofibroma of neurofibroma ...
Pilot study of topical medicine of rapamycin for large diffuse plexiform neurofibroma of neurofibromatosis type 1 - Pilot study of topical medicine of rapamycin for large diffuse plexiform neurofibroma of neurofibromatosis type 1 Pilot study of topical medicine of rapamycinfor large diffuse plexiform neurofibroma of neurofibroma ...
neurofibromatosis type1
1) Application of 0.2% rapamycin gel on one third of the tumor once a day for 2 weeks. 2) Check the skin findings, blood test results, blood level of rapamycin and adverse events after 2 weeks of treatment. If there is no problem, perform application of 0.2% rapamycin gel on two-thirds of the tumor once a day for another 2 weeks. 3) Check the skin findings, blood test results, blood level of rapamycin and adverse events after a total of 4 weeks of treatment. If there is no problem, perform application of 0.2% rapamycin gel on the whole surface of the tumor once a day for another 8 weeks. 1) Application of 0.2% rapamycingel on one third of the tumor once a day for 2 weeks. 2) Check the s ...
Department of Dermatology Graduate School of Medicine, Osaka University
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) Topical RapamycinTherapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) a ...
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex and Neurofibromatosis 1 Topical RapamycinTherapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex and Neu ...
Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)
Phase 1 Study of Tarceva and Rapamycin For Recurrent Low-Grad Gliomas in Children With or Without Neurofibromatosis Type 1 (NF1) Phase 1 Study of Tarceva and RapamycinFor Recurrent Low-Grad Gliomas in Children With or Without Neu ...